What the research found
Sleep apnea remains underdiagnosed despite being common and treatable. The condition disrupts breathing repeatedly during sleep—sometimes dozens of times per hour in moderate-to-severe cases—which triggers oxygen deprivation and activates your sympathetic nervous system. This repeated stress response contributes to elevated blood pressure, inflammation, and metabolic dysfunction.
Clinical clues exist that many people and providers overlook. Unexplained fatigue paired with waking unrefreshed, high blood pressure (especially in younger people or those resistant to medication), or an unexpected elevation in red blood cell count on bloodwork can all point to sleep apnea. People with obesity, those living alone (who may not know they snore), and individuals with resistant hypertension are at particularly high risk.
Treatment options extend beyond CPAP machines. Depending on severity and cause, alternatives include oral appliances, positional adjustments, nasal obstruction treatment, weight loss, and in some cases, GLP-1 medications like tirzepatide (which is now an approved treatment for obesity-related moderate-to-severe sleep apnea). Significant weight loss can sometimes lead to remission, though a repeat sleep study is needed to confirm improvement.
Why it matters for you
If you're tracking blood biomarkers, an unexpected rise in hemoglobin or hematocrit—especially without obvious cause—warrants investigation for sleep apnea. The same applies if you're managing hypertension and find it harder to control than expected, or if you notice persistent elevated resting heart rate or HRV variability that doesn't track with your training load.
Your wearable data is a practical starting point. Devices like Apple Watch, Oura, and WHOOP can flag breathing disturbances, low or variable nighttime oxygen saturation, and unusual respiratory patterns. If these metrics consistently show problems—particularly alongside daytime fatigue, poor recovery despite adequate sleep hours, or mood changes—export the data and discuss it with your provider as a conversation starter, not a diagnosis.
This matters because untreated sleep apnea impairs the very adaptations you're likely optimizing for: it damages attention, memory, and cognitive function, interferes with metabolic health, and makes blood pressure control unnecessarily difficult. If you're investing in recovery protocols, supplementation, or hormone optimization, sleep-disordered breathing actively works against those efforts.
Caveats
- Wearables cannot diagnose sleep apnea; a formal sleep study remains the gold standard
- Occasional abnormal readings on wearables can result from alcohol, illness, nasal congestion, or medications—not necessarily apnea
- The text cites prevalence estimates for sleep apnea in hypertensive populations but does not reference underlying studies
- Treatment efficacy varies individually; weight loss-induced remission requires confirmatory testing before stopping other interventions
- GLP-1 coverage for OSA is insurance-dependent and not universally available